文献速递静脉血栓栓塞慢性静脉疾病

导管导向溶栓与药物机械血栓清除术治疗上肢深静脉血栓的成本效果分析

Catheter-Directed Thrombolysis Versus Pharmacomechanical Thrombectomy for Upper Extremity Deep Venous Thrombosis: A Cost-Effectiveness Analysis.
PubMed 文献 · Ann Vasc Surg · 2018-03-06

2006至2013年赫尔辛基大学医院55例上肢深静脉血栓患者中,24例接受导管导向溶栓(CDT),19例接受Trellis™装置药物机械血栓清除术(PMT),其中43例后续行胸腔镜肋骨切除术。两组即刻技术成功率和1年通畅率相似,但PMT组溶栓时间更短、住院费用更低。

要点

  • CDT组即刻技术成功率91.7%,PMT组100%,差异无统计学意义。
  • CDT组中位溶栓时间21.1小时,PMT组0.33小时,CDT显著更长(P<0.00001)。
  • PMT组急性期住院费用中位数5,975€,CDT组11,476€,PMT显著更低(P<0.00001)。

核心结论

  • CDT与PMT治疗上肢深静脉血栓的临床结果相似,但PMT住院时间更短、监护强度更低,总费用更低。

研究设计与样本

  • 2006至2013年赫尔辛基大学医院55例上肢深静脉血栓患者,24例接受CDT,19例接受Trellis™装置PMT,43例后续行胸腔镜肋骨切除术,前瞻性随访并重复静脉造影。

主要发现

  • 即刻总体技术成功率CDT组91.7% vs PMT组100%(n.s.)。
  • 中位溶栓时间CDT组21.1小时 vs PMT组0.33小时(P<0.00001)。
  • 两组均无操作相关并发症。
  • 1年主要辅助通畅率CDT组91.7% vs PMT组94.7%,两组相似。
  • 两组均无临床深静脉血栓复发。

临床怎么用

  • 本研究中心的做法是以上肢深静脉血栓患者接受CDT或PMT治疗,并前瞻性随访静脉通畅情况。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Upper extremity deep vein thrombosis represents (UEDVT) 2-3% of all deep vein thrombosis. Catheter directed thrombolysis (CDT) was replaced largely by pharmacomechanical thrombolysis (PMT) in our institution. In this study we compared the immediate and 1-year results as well as the total hospital costs between CDT and PMT in the treatment of UEDVT. METHODS: From 2006 to 2013, 55 patients with UEDVT were treated with either CDT or PMT at Helsinki University Hospital. Of them, 43 underwent thoracoscopic rib resection later to relieve phlebography-confirmed vein compression. This patient cohort was prospectively followed up with repeated phlebographies. CDT was performed to 24 patients, and 19 had PMT with a Trellis™ device. Clinical evaluation and vein patency assessment were performed with either phlebography or ultrasound 1 year after the thrombolysis. Primary outcomes were immediate technical success, 1-year vein patency, and costs of the initial treatment. RESULTS: The immediate overall technical success rate, defined as recanalization of the occluded vein and removal of the fresh thrombus, was 91.7% in the CDT group and 100% in the PMT group (n.s.). The median thrombolytic time was significantly longer in CDT patients than that in PMT patients (21.1 vs. 0.33 hr, P < 0.00001). There were no procedure-related complications. The 1-year primary assisted patency rate was similar in both the groups (91.7% and 94.7%). There were no recurrences of clinical DVT. The hospital costs for the acute period were significantly lower in the PMT group than those in the CDT group (medians: 11,476 € and 5,975 € in the CDT and PMT groups, respectively [P < 0.00001]). CONCLUSIONS: The clinical results of the treatment of UEDVT with CDT or PMT were similar. However, PMT required shorter hospital stay and less intensive surveillance, leading to lower total costs.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mahmoud O, Vikatmaa P, Räsänen J, et al. Catheter-Directed Thrombolysis Versus Pharmacomechanical Thrombectomy for Upper Extremity Deep Venous Thrombosis: A Cost-Effectiveness Analysis. Ann Vasc Surg. 2018. PMID: 29522873. doi:10.1016/j.avsg.2018.01.104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。